Status:
WITHDRAWN
Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer
Lead Sponsor:
Carol Fabian, MD
Collaborating Sponsors:
Intergenetics, Inc.
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
A study to examine the potential associations between common single nucleotide polymorphisms and pre-cancerous conditions in breast tissue specimens from postmenopausal women.
Detailed Description
A study to examine the correlation between single nucleotide polymorphisms (SNPs) affecting steroid and carcinogen metabolism and benign breast tissue cytomorphology collected via random periareolar f...
Eligibility Criteria
Inclusion
- postmenopausal women on or off hormone replacement therapy
- at high risk of developing breast cancer determined by family or personal history
- postmenopausal women not on hormone replacement therapy for at minimum six months prior to corresponding aspiration
- willing to participate in companion protocol (KUMC HSC#4601) for random periareolar fine needle aspiration (RPFNA) for correlational studies
Exclusion
- women who have been on raloxifene, tamoxifen, letrozole, anastrozole or exemestane within the six months prior to RPFNA.
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 12 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00329017
Start Date
May 1 2005
End Date
November 12 2015
Last Update
October 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160